Skip to main content
. 2020 Apr 2;46(4):62–68. doi: 10.14745/ccdr.v46i04a02

Table 2. Extent of available surveillance data to assess effectiveness of RSV vaccine for public health priorities by target groups.

Public health priority Public health parameters
Measures used by NACI to assess burden of illness
Incidence Study
settingsa
Virus strain High risk
populationsb
Infant hospitalization IMPACTc
CIHIc
IMPACTc
CIHIc
IMPACTd IMPACTd CIHIc
Infant death IMPACTc
CIHIc
IMPACTc
CIHIc
IMPACTd IMPACTd CIHIc
Infection in remote communities (child) IMPACTc
CIHIc
IMPACTc
CIHIc
IMPACTc IMPACTc
CIHIc
Child hospitalization IMPACTc
CIHIc
IMPACTc
CIHIc
IMPACTd IMPACTd CIHIc
Child death IMPACTc
CIHIc
IMPACTc
CIHIc
IMPACTd IMPACTd CIHIc
Senior hospitalization CIHIc CIHIc NDe CIHIc
Senior death CIHIc CIHIc NDe CIHIc

Abbreviations: CIHI, Canadian Institute for Health Information; IMPACT, Immunization Monitoring Program ACTive; NACI, National Advisory Committee on Immunization; ND, no data; RSV, respiratory syncytial virus

a Study settings may include: community, primary care, hospital, nosocomial

b High risk populations for RSV include: infants, children and seniors with underlying medical conditions

c Limited data - yellow

d Sufficient data - grey

e No data - pink